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Abstract
Alveolar osteitis (AO) is a common complication after third molar surgery. One of the most studied agents in its 
prevention is chlorhexidine (CHX), which has proved to be effective.
Objectives: The aim of this randomized double-blind clinical trial was to evaluate the efficacy of 0.2% bioadhesive 
chlorhexidine gel placed intra-alveolar in the prevention of AO after the extraction of mandibular third molars and 
to analyze the impact of risk factors such as smoking and oral contraceptives in the development of AO.
Study Design: The study was a randomized, double-blind, clinical trial performed in the Ambulatory Surgery 
Unit of Hospital Vall d’Hebron and was approved by the Ethics Committee. A total of 160 patients randomly re-
ceived 0.2% bioadhesive gel (80 patients) or bioadhesive placebo (80 patients).
Results: 0.2% bioadhesive chlorhexidine gel applied in the alveolus after third molar extraction reduced the incidence 
of dry socket by 22% compared to placebo with differences that were not statistically significant. 
Smoking and the use of oral contraceptives were not related to higher incidence of dry socket. Female patients and 
the difficulty of the surgery were associated with a higher incidence of AO with statistically significant differences. 
0.2% bioadhesive chlorhexidine gel did not produce any of the side effects related to chlorhexidine rinses.
Conclusions: A 22% reduction of the incidence of alveolar osteitis with the application of 0.2% bioadhesive chlo-
rhexidine gel compared to placebo with differences that were not statistically significant was found in this clinical 
trial. The lack of adverse reactions and complications related to chlorhexidine gel supports its clinical use spe-
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cially in simple extractions and adds some advantages compared to the rinses in terms of duration of the treatment 
and reduction of staining and taste disturbance.
Key words: Alveolar osteitis, dry socket, chlorhexidine bioadhesive gel, mandibular third molar surgery.
Introduction
Alveolar osteitis (AO) is a common complication after 
the extraction of teeth that was first defined in 1896 
by Crawford. There are different terms to refer to this 
condition such as dry socket, localized osteitis, postop-
erative alveolitis, alveolalgia, alveolitis sicca dolorosa, 
septic socket, necrotic socket, localized osteomyelitis or 
fibrinolytic alveolitis. (1) The average incidence for all 
dental extractions ranges from 0.49% to 68.1% and in 
third molar surgery ranges from 1% to 30% (2,3).
There are different subjective clinical symptoms and 
Blum standardized the definition for AO: postoperative 
pain in an around the extraction site, which increases 
in severity at any time between 1 and 3 days after the 
extraction accompanied by a partially or totally disin-
tegrated blood clot within the alveolar socket with or 
without halitosis (1). The cause of AO has not been 
established but Birn investigated the role of a locally 
increased fibrinolytic activity in its pathogenesis and it 
is believed to have a multifactorial origin with several 
agents like oral micro-organisms, difficulty and trauma 
during extractions, roots or bone fragments remaining 
in the wound, excessive curettage of the alveolus, the 
use of anesthesia with vasoconstrictor, oral contracep-
tives, or smoking (1).
Systemic antibiotics have proved to be effective in re-
ducing the frequency of AO and wound infection after 
third molar surgery, (4) but the increasing rate of ad-
verse reaction to antibiotics (around 6-7% of the pa-
tients) (5) and bacterial resistance has lead to investigate 
new treatments. Several pharmacological interventions 
have been studied in the prevention of AO such as an-
tibacterial agents, antifibrinolytic agents, antiseptic 
agents, obtundent dressings, steroid-anti-inflammatory 
agents, clot-support agents and recently plasma rich in 
growth factors (1,6). The antiseptic rinse most studied is 
chlorhexidine which has reported reductions in alveolar 
osteitis rates from 24.5% up to 80.2%. (1,7-11). Recently 
some investigations have studied the effect of 0.2% bio-
adhesive chlorhexidine gel with reductions of 60-70% 
in the incidence of AO (12-17).   
The aim of this study is to evaluate the efficacy of 0.2% 
bioadhesive chlorhexidine gel in the prevention of AO 
after the extraction of mandibular third molars and to 
analyze the impact of risk factors such as smoking and 
oral contraceptives in the development of AO.
Material and Methods
The study was a randomized, double-blind, placebo-
controlled, single-center, parallel-group clinical trial 
conducted at the Minor Outpatient Surgery Unit of  our 
Hospital from april 2008 until november 2010. 
The sample size was calculated previously in collabora-
tion with the Statistics Department with the program 
Epi-info, with 80 patients treated with chlorhexidine gel 
and 80 with placebo, with a significance level of 5% and 
a statistical power of 80% to detect as significant a dif-
ference corresponding to an  incidence of 11% in the 
chlorhexidine group and 30% in the placebo group. 
The study was approved by the Ethics Committee of the 
Hospital in December 2007. All the patients received 
prior to the intervention a document that described the 
study and signed an Informed Consent following the 
Principles of the Helsinki Declaration.
Chlorhexidine (0.2% Bioadhesive Chlorhexidine gel) 
and placebo gels were provided by Laboratorios Lacer 
(C/ Sardenya 350, Barcelona, Spain) in white single 
dose tubes of 10ml. Randomization of patients was per-
formed by the Department of Statistics by a random list 
grouping the total of 160 patients in groups of 4 so that 
the distribution of the two groups (chlorhexidine and 
placebo) were homogeneous throughout the sample.
Clinical history of the patient was done noting the sex, 
age, phone number, use or not of oral contraceptives, 
smoking (if so also the amount), medical history, regular 
medication and reason for extraction. Ortopantomog-
raphy was used in order to classify the difficulty of the 
extraction according to Koerner’s index, a scale that clas-
sifies the difficulty of the extractions according to the po-
sition of the third molar in the Winter classification (me-
sio-angular, disto-angular, horizontal or vertical) and the 
relationship between the impacted lower wisdom tooth to 
the ramus of the mandible and the 2nd molar in the Pell 
and Gregory classification and were included the extrac-
tions with a difficulty index between 4 and 7. Exclusion 
criteria were unwillingness to participate, patients with 
pericoronitis, active infection or antibiotic treatment at 
the time of surgery or in the last two weeks, to avoid false 
results due to the presence of active infection, patients 
with significant systemic disease, pregnancy, immuno-
compromised patients, AIDS or with associated bone pa-
thology. Patients that were taking oral contraceptives or 
smokers were not excluded. 
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The operation was performed under local anesthesia 
with inferior alveolar and lingual nerves block and lo-
cal infiltration. The anesthetic used was 40 mg articaine 
with epinephrine hydrochloride 0.05% (Ultracain®, 
Laboratorios Normon, Madrid. Spain). The extraction 
was done with elevators when it was simple or by re-
moving the surrounding bone and sectioning the tooth 
and the roots when it was necessary. After rinsing the 
socket with saline and gentle curettage, a single dose 
of bioadhesive gel (0.2% chlorhexidine or placebo ac-
cording to the random list and neither the surgeon nor 
the patient knew the substance) was introduced and 
posteriorly suture with vicryl 4/0. Finally a compres-
sive gauze was introduced during 30-45 minutes and 
cold was applied locally. A document with the postop-
erative instructions and treatment was given (diclofenac 
50 mg every 8 hours alternated with metamizol 575 mg 
every 8 hours and omeprazole 20 mg per day without 
postoperative administration of bioadhesive gel). Epi-
demiologic and intraoperative data such as age, gender, 
smoking, oral contraceptives, difficulty of the extrac-
tion, side of the extraction, cause of the extraction, type 
of operation or surgical time were collected.
At the second or third postoperative day a first control 
was done in the office and a second control was done af-
ter 7-8 days in order to diagnose an AO according to the 
following criteria: uncontrollable pain with the analge-
sia prescribed between 1 and 3 days after the extraction 
with one or more of the following: partial or total dis-
integration of the clot, detritus, empty socket/exposed 
alveolar bone +/- halitosis. When a dry socket was diag-
nosed the following measures were implemented: Re-
alization of a microbiological culture, careful irrigation 
with chlorhexidine digluconate mouthwash 0.12%, ap-
plication of bioadhesive chlorhexidine gel 0.2%, suture 
removal (if necessary in some cases due to difficulty of 
hygiene producing a valve mechanism in the gum allow-
ing entry of detritus in the socket but not exit), variation 
of the medication with the introduction of an antibiotic: 
amoxicillin-clavulanate or clindamycin if allergic to 
penicillin. Possible complications and treatment intoler-
ance were noted. A Chi-Square test was used when  the 
expected frequencies were greater than 5, otherwise a 
Fisher test was used. When the dependent variable was 
qualitative ordinal the statistic test used was Kendall’s 
Tau-b. It was considered as statistically significant dif-
ferences for 5% significance level .
Results
160 patients were studied, 80 of them received 0.2% 
bioadhesive chlorhexidine gel and the other 80 a pla-
cebo gel (Table 1). Of the 160 patients, 53.8% (86) were 
women and the mean age was 25.04 years. 26 out of 86 
women were taking oral contraceptives and  67 patients 
were smokers (41.80%). The difficulty of the tooth ex-
traction according to Koerner’s scale was 4: 49 patients 
(30.60%), 5: 49 patients (30.60%), 6: 42 patients (26.25%) 
and 7: 20 patients (12.50%) and the third molar extrac-
tion was simple (with elevators) in 61 patients (38.12%) 
and surgical (bone removal +/- root sectioning) in 99 
patients (61.87%). 118 patients tolerated the treatment 
(73.75%) and 42 did not (26.25%) with gastrointestinal 
discomfort in 30 patients, dizziness in 10 patients and 
skin rash in 2 of them. The complications of the proce-
dure were temporal paresthesia of the inferior alveolar 
nerve in 4 patients (2.5%), 3 phlegmons (1.87%), 1 sock-
et bleeding (0.62%) and 1 TMJ pain (0.62%). 14 patients 
with AO received chlorhexidine gel (17.50%) and 18 pa-
tients with AO  received placebo (22.50%) (X2 Pearson 
= 0,625; p = 0,554), this represented a 22.22% reduction 
in the occurrence of AO in the chlorhexidine  group but 
statistical differences were not significant (Table 2). No 
statistical differences were detected in the incidence of 
AO in patients that were taking oral contraceptives or 
smokers. A significant association in the degree of dif-
ficulty was observed. If the difficulty of the extraction 
was 4, a 10% of alveolar osteitis was found, whereas 
if the difficulty was 5 or greater alveolar osteitis was 
observed in percentages above 20%. 
Discussion
The results of this study revealed that the intra-alveolar 
placement of 0.2% bioadhesive chlorhexidine gel might 
reduce the frequency of alveolar osteitis in 22.22% 
compared to the control group. There are few papers 
that have studied the effectiveness of  the biadhesive 
chlorhexidine gel in the prevention of alveolar osteitis. 
Torres-Lagares et al found a 42.65% reduction in a pilot 
study with 30 patients (16) a 63.33% reduction in a sam-
ple of 103 patients (12), and posteriorly a 57.15% reduc-
tion in 38 patients with bleeding disorders (15), Hita-
Iglesias et al (13) observed a 70% reduction in a study 
that compared effectiveness of chlorhexidine gel versus 
chlorhexidine rinse in 73 patients, Haraji found a 65.4% 
reduction in a split-mouth clinical trial with 80 patients 
(14). Rodríguez-Pérez et al (17) studied the effective-
ness of chlorhexidine gel at 0.2% and 1% and observed 
that there were no significant differences in AO after 
surgical extraction of mandibular third molars. 
The effectiveness of the chlorhexidine mouthwash dur-
ing the surgery and after one week has been demon-
strated in several studies. Hermesch et al found a 44.2% 
reduction (3), Larsen a 60.3% reduction (8), Tjernberg 
a 80.2% reduction (9), Ragno and Szkutnik a 51.8% re-
duction (11), Bonine a 56% reduction (10) and Metin a 
42% reduction (18). In a meta-analytic review by Caso 
(2) it was concluded that rinsing with chlorhexidine on 
the day of the surgery and several days after may reduce 
the incidence of AO. In a paper based on a Cochrane 
Review (19) concluded that there is some evidence that 
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rinsing with chlorhexidine (0.12% and 0.2%) or placing 
chlorhexidine gel (0.2%) in the sockets of extracted teeth, 
provides a benefit in preventing dry socket. However, 
a recent systematic review by Yengopal (20) could not 
identify sufficient evidence supporting the use of chlo-
rhexidine for the prevention of AO, and posteriorly Ri-
chards (21) reviewed its effectiveness and concluded that 
there is insufficient evidence on which to recommend the 
use of chlorhexidine to prevent alveolar osteitis.
The difficulty of the extraction (according to Koerner’s 
Treatment group
0.2% CHX gel (n=80) Placebo gel (n=80)   
Age (years)
Mean 25,89 24,19   
SD 7,741 5,04   
n % n % Total
Sex      p
Male 36 48,65% 38 51,67% 74 0,874 Female 44 51,16% 42 49,14% 86
Smoker       
Yes 33 49,25% 34 51,11% 67
1No 47 50,54% 46 49,74% 93
Orales
contraceptives       
Yes 12 46,15% 14 53,85% 26
0,64 No 32 53,33% 28 46,67% 60
Difficulty of the 
extraction 
(Koerner scale)       
4 27 55,10% 22 44,90% 49
0,584 5 22 44,90% 27 55,10% 496 22 52,38% 20 47,62% 42
7 9 45,00% 11 55,00% 20
Treatment 
tolerance       
Yes 62 52,54% 56 47,46% 118
0,369 No 18 42,86% 24 57,14% 42
Side of the 
extraction       
Left (38) 35 46,67% 40 53,33% 75
0,263 Right (48) 45 52,94% 40 47,06% 85
Type of operation      
Bone removal 
+/- root 
sectioning 44 44,44% 55 55,56% 99
0,052 Simple 36 59,02% 25 40,98% 61
Surgical time      
<10 min 49 60,49% 32 39,51% 81
0,005 
10-20 min 28 40,00% 42 60,00% 70
21-30 min 3 37,50% 5 62,50% 8
>30 min 0 0,00% 1 100,00% 1
Table 1. Description of patients in each group.
Chlorhexidine Placebo Total
AO Yes 14 (17.5%) 18 (22.5%) 32 
AO No 66 (82.5%) 62 (77.5%) 128 
Total 80 80 160 
Risk 0,175 0,225 0,2 
 Point estimate [95% Conf. Interval] 
Risk difference -0,05 -0,17         0,07 
Risk ratio 0,77 0,41         1,45 
Prev. frac. ex 0,22 -0,453       0,58 
Table 2. Risk results of AO in the 0.2% bioadhesive chlorhexidine and the placebo groups.
chi2(1) =     0.63  Pr>chi2 = 0.4292.
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scale) was higher than other studies (12,13) and 61.8% 
of the extractions were surgical. Wether if the extrac-
tion was simple or surgical and the duration of the oper-
ation (two important factors in the pathogenesis of AO) 
are not described in other studies and this could be one 
reason of the lower reduction of the incidence of AO of 
this clinical trial. A higher incidence of alveolar osteitis 
was found in the surgical extractions (23.23%) than in 
simple extractions (14.75%) p=0.226, as well as opera-
tions longer than 10 minutes had higher incidence of al-
veolar osteitis (21.43-25%) than shorter than 10 minutes 
(17.28%) p=0.284 but statistically differences were not 
significant. 
Risk factors associated to AO such as smoking (41.9% 
of the patients) or oral contraceptives (30.2% of women) 
did not influence in this study. These results are similar 
to other recent studies with chlorhexidine gel by Torres-
Lagares (12,16) and Hita-Iglesias (13) that did not find 
statistically difference regarding these risk factors. 
Hermesch (3) observed that smoking was not related to 
a statistically significant increase of AO but there was a 
47% increase in the incidence of AO in women taking 
oral contraceptives. 
None of the patients of this study complained about teeth 
or mucosa staining, mucosa erosion, taste disturbance 
or parotitis which are related to chlorhexidine rinses. 
(18,22) This local effect of the gel without alteration to 
the rest of the oral cavity and the longer effect due to it 
is bioadhesive are some advantages of the gel in com-
parison to the mouthwash.
The sample size of the study was appropriate in order 
to assess the effects of intra-alveolar placement of chlo-
rhexidine gel on the incidence of AO and is the longest 
published with chlorhexidine gel. Haraji (14) also stud-
ied a total of 160 mandibular third molars extractions 
but in 80 patients in a split-mouth clinical trial. Torres-
Lagares series studied 30 (16), 103 (12) and 38 (15) pa-
tients, Hita-Iglesias (13) 73 patients and  Rodríguez-
Pérez (17) 88 patients.
A 26.25% of the patients did not tolerate the postopera-
tive treatment due to gastrointestinal discomfort associ-
ated to metamizol in the majority of them which was 
solved by changing the analgesic to paracetamol 1g. 
5.6% of the patients suffered complications that could 
be treated without any sequela, which was similar to 
Hermesch (3).
The study was balanced in terms of sex, age, smoking, 
oral contraceptives, difficulty of the extraction and side 
of the extraction. The almost equal number between 
male and female patients was taken in consideration in 
Haraji (14) and Rodríguez-Pérez (17) studies, but not 
in Torres-Lagares (12,16) and Hita-Iglesias (13) studies 
which present a higher proportion of females. We have 
found a higher incidence of AO in women (29.07%) than 
in men (9.46%) p=0.003 which could be interpreted as 
the female sex might be a risk factor of AO (1,23). This 
is a very important issue that has not been described in 
other studies which probably with a balanced propor-
tion of males and females would have lower rates of AO. 
(12,13,16) The mean age of the patients was similar to 
other studies (12,13,17) and the taking of oral contra-
ceptives (30.23%) is higher than other similar studies 
that have an incidence around 14% (12,13). This was 
considered a risk factor of AO (1) and some studies with 
chlorhexidine rinse found an increase in AO in females 
using oral contraceptives (3,10) but other studies with 
chlorhexidine gel did not find any difference (12,13). 
Smoking did not increase the incidence of AO in this 
study. Hita-Iglesias (13) and Hermesch (3) did not find 
an increase of AO in smokers, but the majority of the 
studies observed a higher incidence of AO in smokers 
(1,10,12,18).
There are many studies and reviews that support that 
chlorhexidine rinses and gel reduce the incidence of AO 
after the extraction of mandibular third molars. A 22% 
reduction of the incidence of alveolar osteitis with the 
aplication of 0.2% bioadhesive chlorhexidine gel com-
pared to placebo with differences that were not statisti-
cally significant was found in this clinical trial. The lack 
of adverse reactions and complications related to chlo-
rhexidine gel supports its clinical use in simple extrac-
tions and adds some advantages compared to the rinses 
in terms of duration of the treatment and reduction of 
staining and taste disturbance.
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